You are here

Drug Forecast

Optimizing Adherence to Highly Active Antiretroviral Therapy: A Focus on Fosamprenavir

Nathaniel Eraikhuemen, PharmD, Natalie Perry, PharmD, Evans Branch III, PharmD, Daryl Norwood, PharmD, and Marlon Honeywell, PharmD
PDF version: 
The authors review fosamprenavir (Lexiva™) for the treatment of HIV infection.